CompletedNCT03692910
SAGE-217 in people with Bipolar I/II Disorder With a Current Major Depressive Episode
This study is completed in the United States. It is testing SAGE-217 for depression.
Bipolarity, DepressionOtherFrom 18 Years to 65 Years
Study directory
Back to overviewMental health studies with practical context.
Public study records, presented in a clearer and more patient-friendly format for mental health research discovery.
CompletedNCT03713658
Ability of Conducting a Study of Oral Risperidone Followed by Paliperidone Palmitate in Rwandan Healthcare Facilities
This study is completed in Rwanda. It is testing ability of Conducting a Study of Oral Risperidone Followed by Paliperidone Palmitate for Schizophrenia.
SchizophreniaOtherFrom 18 Years to 70 Years
CompletedNCT05893862
Effect Of A Supratherapeutic Dose Of Elpipodect On The QTc Interval for schizophrenia
This study is completed in the United States. It is testing Effect Of A Supratherapeutic Dose Of Elpipodect On The QTc Interval for schizophrenia.
SchizophreniaOtherFrom 18 Years to 60 Years
CompletedEUCTR 2017-000497-11
Effect of ALKS 3831 Compared to Olanzapine on Body Weight for schizophrenia
This study is completed in Austria, in Germany, in Spain, .... It is testing Effect of ALKS 3831 Compared to Olanzapine on Body Weight for schizophrenia.
Bipolarity, SchizophreniaOther
TerminatedNCT00907985
Effect of Single Doses of Drug A (Lamotrigine) and Drug B (Vofopitant) Alone and for Bipolarity
This study has public registry information in Germany. It is testing effect of Single Doses of Drug A (Lamotrigine) and Drug B (Vofopitant) Alone and for Bipolarity.
BipolarityOtherFrom 18 Years to 65 Years
CompletedNCT00490971
Effectiveness of Effectiveness and Safety of Extended-Release (ER) Paliperidone Compared With Placebo in Bipolarity
This study is completed in the United States, in France, in Bulgaria, .... It is testing Effectiveness and Safety of Extended-Release (ER) Paliperidone Compared With Placebo for Bipolarity.
BipolarityOtherFrom 18 Years to 65 Years
CompletedNCT01527305
Effectiveness of effectiveness and Safety of Paliperidone Palmitate in schizophrenia
This study is completed in China, in Malaysia, in South Korea, .... It is testing effectiveness and Safety of Paliperidone Palmitate for schizophrenia.
SchizophreniaOtherFrom 18 Years to 65 Years
CompletedNCT01072929
Armodafinil Treatment for depression
This study is completed in the United States. It is testing armodafinil Treatment for depression.
Bipolarity, DepressionOtherFrom 18 Years to 65 Years
CompletedNCT02734693
Dasotraline for ADHD
This study is completed in the United States. It is testing dasotraline for ADHD.
ADHDOtherFrom 6 Years to 12 Years
CompletedNCT03231800
Dasotraline for ADHD
This study is completed in the United States. It is testing dasotraline for ADHD.
ADHDOtherFrom 6 Years to 12 Years
CompletedNCT07193563
ENX-102 for anxiety
This study is completed in the United States. It is testing ENX-102 for anxiety.
AnxietyOtherFrom 18 Years to 70 Years
CompletedNCT00309699
Flexible Doses of Extended-release (ER) Paliperidone Compared With Flexible Doses of Quetiapine and Placebo for Bipolarity
This study is completed in the United States, in Greece, in Lithuania, .... It is testing Flexible Doses of Extended-release (ER) Paliperidone Compared With Flexible Doses of Quetiapine and Placebo for Bipolarity.
BipolarityOtherFrom 18 Years to 65 Years